Kengo Koike, M.D., Ph.D. | American Lung Association

Kengo Koike, M.D., Ph.D.

National Jewish Health
Understanding Enzyme Involved in Development of COPD

Chronic obstructive pulmonary disease (COPD) is usually caused by cigarette smoking. There is no cure, and the mechanisms behind the development and progression of the disease remain incompletely understood. We will study the process that produces fat-like substances called bioactive lipids in lung cells. The levels of these lipids, called sphingolipids are significantly changed in plasma of COPD patients who are prone to have inflammation episodes in their lung. By understanding a key enzyme that controls how much sphingolipid is synthesized, we can develop tools to reduce the chance for lung cells to be destroyed by smoke and ultimately decrease lung injury and inflammation caused by smoking.

Ask An Expert

Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

Get help
We need your generous support

Make a difference by delivering research, education and advocacy to those impacted by lung disease.


LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

Get involved
Join the fight for healthy lungs and healthy air.
Donate Now.